## Abstract Dyskinesia is a common adverse effect complicating chronic dopaminergic therapy for Parkinson's disease. Movements are frequently choreic in nature and have been ascribed to overstimulation of βsupersensitiveβ striatal postsynaptic dopamine receptors. Anticholinergic medications, despit
rCBF changes associated with PPN stimulation in a patient with Parkinson's disease: A PET study
β Scribed by Antonio P. Strafella; Andres M. Lozano; Benedicte Ballanger; Yu-Yan Poon; Anthony E. Lang; Elena Moro
- Publisher
- John Wiley and Sons
- Year
- 2008
- Tongue
- English
- Weight
- 92 KB
- Volume
- 23
- Category
- Article
- ISSN
- 0885-3185
No coin nor oath required. For personal study only.
β¦ Synopsis
Abstract
Gait disturbances and akinesia are disabling symptoms in advanced Parkinson's disease (PD). The pedunculopontine nucleus (PPN) is involved in locomotion, control of posture, and behavioral states [i.e. wakefulness, rapid eye movement (REM) sleep]. Some reports have suggested that modulation of the activity of the PPN with deep brain stimulation (DBS) may be beneficial in the treatment of gait dysfunction and akinesia. To gain some insights on effects of PPNβDBS in the human brain, we used [^15^O] H~2~O positron emission tomography (PET) to measure changes in regional cerebral blood flow (rCBF) at rest during Off and On stimulation in an advanced PD patient with unilateral PPNβDBS. PPNβDBS increased rCBF in different subcortical areas most notably the thalamus, bilaterally. Doubleβblinded clinical evaluation revealed an improvement in motor function by βΌ20%. The PET changes provide for the first time evidence in the human brain that PPNβDBS may be able to influence and modify rCBF of closely connected subcortical structures. Given the importance of the PPN in locomotion, control of posture, and behavioral states, DBS may have significant implication for more complicated forms of movement disorders where deterioration of gait, postural instability, and REM sleep behavior disorders are very disabling. Β© 2008 Movement Disorder Society
π SIMILAR VOLUMES
A patient with Gilles de la Tourette syndrome later developed Parkinson's disease in middie age. This was accompanied by amarkedreduction in the frequency of tics but levodopa toxicity exacerbated the tics. The dopamine hypothesis of tic disorders is supported by this observation.
## Abstract Patients with advanced Parkinson's disease (PD) develop disabling axial symptoms, including gait disturbances, freezing and postural instability poorly responsive to levodopa replacement therapy. The pedunculopontine nucleus (PPN) is involved in locomotion, control of posture, and behav
## Abstract ## Objective: The aim of this work was to investigate the prevalence of camptocormia and the clinical characteristics of patients with camptocormia in a large population of PD patients. ## Background: Although camptocormia has been recognized as a prominent phenomenon in PD, the prev